JOIN US! Introducing the MRCT Center “Leaning In” webinar series focusing on practical approaches for improving diversity in clinical trials. Each webinar will highlight a topic covered in the our “Achieving Diversity, Inclusion, and Equity in Clinical Research” Guidance Document and Toolkit, Wednesdays 11am – 12noon ET. MORE
The MRCT Center is proud to announce the release of Achieving Diversity, Inclusion, and Equity in Clinical Research Guidance Document. A comprehensive framework with resources and tools to improve diversity in clinical trials. It is a time to engage, to commit, and to act. MORE
The African Vaccine Regulatory Forum (AVAREF) and the MRCT Center are initiating a partnership focused on capacity building of ethics committee members. AVAREF and the MRCT Center will collaborate to create and deliver an ethics training course for AVAREF country-members’ National Ethics Committees (NECs)/Institutional Review Boards (IRBs).
Nov 03, 2020
MRCT Program Director Deborah Zarin in STAT’s Pharmalot “Critics say new NIH policy on scientific data sharing falls short”
MRCT Program Director, Deborah A. Zarin commented on the National Institute of Health’s release of its final policy for managing and sharing publicly funded scientific data in STAT’s Pharmalot. Read article here
Oct 02, 2020
In Science Magazine, “How to fix the GDPR’s frustration of global biomedical research” with MRCT Faculty Co-Director, Mark Barnes and Senior Advisor, David Peloquin
In Science Magazine, “How to fix the GDPR’s frustration of global biomedical research”, MRCT Faculty Co-Director, Mark Barnes and Senior Advisor, David Peloquin, both of Ropes and Gray, along with Barbara Bierer and colleagues, analyzed challenges to the European Union’s General Data Protection Regulation to share biomedical research data beyond the EU. Read article here.
Discussion topic: MRCT Center Leaning In webinar: Role of Data in Diversity: Genetics & RWD Find webinar info here.
Discussion Topic: Decentralized clinical trials
Discussion Topic: Communicating with National Regulatory Authorities Regarding Research Misconduct